IL6 and neoplasm: Primary tumor-secreted IL-6 activated STAT3 in lymphatic endothelial cells, which then induced the expression of hypoxia-inducible factor 1 (HIF-1), vascular endothelial growth factor (VEGF), and chemokine ligand 5 (CCL5).